These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11858351)
1. Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies. Feldmann M; Maini RN Joint Bone Spine; 2002 Jan; 69(1):12-8. PubMed ID: 11858351 [TBL] [Abstract][Full Text] [Related]
2. How does infliximab work in rheumatoid arthritis? Maini RN; Feldmann M Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S22-8. PubMed ID: 12110154 [TBL] [Abstract][Full Text] [Related]
3. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment. Harriman G; Harper LK; Schaible TF Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I61-4. PubMed ID: 10577975 [No Abstract] [Full Text] [Related]
4. Infliximab treatment of rheumatoid arthritis. Maini SR Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044 [TBL] [Abstract][Full Text] [Related]
5. Infliximab: a new treatment for rheumatoid arthritis. Emery P Hosp Med; 2001 Mar; 62(3):150-2. PubMed ID: 11291464 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy. Boers M; Arthritis Rheum; 2001 Nov; 44(11):2703-4. PubMed ID: 11710727 [No Abstract] [Full Text] [Related]
7. Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience. Richard-Miceli C; Dougados M BioDrugs; 2001; 15(4):251-9. PubMed ID: 11437690 [TBL] [Abstract][Full Text] [Related]
8. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis]. Mugnier B; Bouvenot G Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394 [TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE). Bondeson J; Maini RN Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775 [TBL] [Abstract][Full Text] [Related]
10. Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us? Feldmann M; Maini RN J Immunol; 2010 Jul; 185(2):791-4. PubMed ID: 20601610 [TBL] [Abstract][Full Text] [Related]
11. [New therapeutic methods against rheumatoid arthritisp6. Antibodies against TNFalpha significant for the progress]. Bondeson J Lakartidningen; 1997 Jan; 94(1-2):42-5. PubMed ID: 9053603 [TBL] [Abstract][Full Text] [Related]
12. TNF inhibitors: a new age in rheumatoid arthritis treatment. Anderson DL Am J Nurs; 2004 Feb; 104(2):60-8; quiz 68-9. PubMed ID: 14767382 [No Abstract] [Full Text] [Related]
14. [Infliximab for therapy of rheumatoid arthritis]. Amano K Nihon Rinsho; 2005 Jan; 63 Suppl 1():517-20. PubMed ID: 15799410 [No Abstract] [Full Text] [Related]
15. Treatment of rheumatoid arthritis by TNF-blocking agents. Graninger W; Smolen J Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849 [TBL] [Abstract][Full Text] [Related]
16. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. Keating GM; Perry CM BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485 [TBL] [Abstract][Full Text] [Related]
17. [Fully human anti TNF-alpha monoclonal antibodies (adalimumab, golimumab)]. Hirohata S Nihon Rinsho; 2007 Jul; 65(7):1202-8. PubMed ID: 17642233 [TBL] [Abstract][Full Text] [Related]